 |
인쇄하기
취소
|
Chong Kun Dang seeks link with Scottish Biomedical
Chong Kun Dang Pharmaceutical Co. and Scottish Biomedical agreed to conduct a joint research on new antidiabetic drugs in Glasgow on May 25.
The Korean Health Industry Development Institute (KHIDI) said that the research collaboration between the two companies will primarily focus on the development of new drugs to treat diabetes with Scottish Biomedical providing biological and medicinal ch...
The Korean Health Industry Development Institute (KHIDI) said that the research collaboration between the two companies will primarily focus on the development of new drugs to treat diabetes with Scottish Biomedical providing biological and medicinal ch...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.